NEUR-4914: Drug Development in Neuroscience
Description: Current approaches and pitfalls for developing therapeutics for treating disorders of the central nervous system (CNS). Theoretical issues and practical applications targeting identification, high-throughput screening, pharmacokinetics and pharmacodynamics, preclinical testing, clinical trials, and the FDA approval process. Ethical implications for drug development and testing.
Pathways: N/A
Course Hours: 3 credits
Corequisites: N/A
Crosslist: N/A
Repeatability: N/A
Sections Taught: 5
Average GPA: 3.67 (A-)
Strict A Rate (No A-) : 53.83%
Average Withdrawal Rate: 1.25%
| Matthew Buczynski | 2024 | 73.2% | 23.1% | 2.5% | 0.0% | 0.0% | 1.3% | 3.67 | 5 |